Press Room - Sanofi US News

Menu

Media Room Menu

Month Year

Month Year

Apr 20, 2007

The Lancet publishes PREVAIL study results showing LOVENOX® superiority over unfractionated heparin for reducing the risk of venous thromboembolism in patients with acute ischemic stroke
Apr 17, 2007

FDA Licenses First U.S. Vaccine for Humans Against Avian Influenza

sanofi pasteur receives first U.S. license for a vaccine against avian influenza in humans marking an important milestone in pandemic preparedness
Apr 17, 2007

The U.S. Food and Drug Administration Approves New ACTONEL Dose to Treat and Prevent Postmenopausal Osteoporosis
Mar 26, 2007

Rimonabant USA: Update
Mar 25, 2007

Data Shows That Omission of Venous Thromboembolism (VTE) Prophylaxis in Hospitalized Medical Patients Is Frequent and Leads to Higher Risk of Deep-Vein Thrombosis (DVT)
Mar 16, 2007

Award-winning actress and singer Lainie Kazan travels across the country urging Americans to understand the signs, symptoms and risk factors for Deep-Vein Thrombosis (DVT)
Mar 13, 2007

ALLEGRA® (fexofenadine hydrochloride) Oral Supsension now available to help manage seasonal allergy symptoms in children
Mar 12, 2007

Sanofi-aventis Debuts AgingWithBeauty.com
Mar 6, 2007

Actor Cheryl Hines is tired of counting sheep to sleep…and is painting them instead
Mar 1, 2007

New, Once-a-Day Fixed-Dose Combination Against Malaria Now Available
Feb 27, 2007

Sanofi Pasteur Statement
Feb 12, 2007

Rimonabant USA: Update
Feb 12, 2007

Sanofi-aventis announces update to US Prescribing Information for KETEK® (telithromycin)
Feb 7, 2007

FDA grants priority review to LOVENOX® (enoxaparin sodium injection) supplemental new drug application (sNDA) for acute heart attack
Feb 6, 2007

Tim Rothwell appointed Chairman of Sanofi-aventis Group U.S. pharmaceutical activities; Greg Irace named President and CEO of U.S. pharmaceutical operations
Feb 1, 2007

Sanofi-aventis applauds new national standards for prophylaxis of venous thromboembolism in surgical patients
Jan 25, 2007

FDA Advisory Committee Recommends Licensure of New Pediatric Combination Vaccine

If approved, Pentacel vaccine would be the first pediatric combination vaccine in the U.S. to immunize against diphtheria, tetanus, pertussis, polio, and Haemophilus influenzae type b (Hib)
Jan 19, 2007

S-1 oral anticancer agent improves patients’ survival in adjuvant gastric cancer trial versus surgery alone
Dec 20, 2006

Sanofi Pasteur Influenza Vaccine Production Tops 170 Million Doses in 2006

Record production capabilities strengthen sanofi pasteur’s global leadership in the fight against seasonal influenza and place the company at the forefront of pandemic readiness
Dec 15, 2006

Sanofi-aventis statement regarding U.S. FDA joint advisory committee recommendation for KETEK® (telithromycin)
Dec 12, 2006

New study shows LOVENOX® (enoxaparin sodium injection) is more effective than unfractionated heparin (UFH) for lowering the risk of venous thromboembolism (VTE) in patients with acute ischemic stroke

The PREVAIL study showed that in acute ischemic stroke patients treated with Lovenox, the risk of having a VTE was lowered by a significant 43% with no statistically significant increase in clinically important bleedings when compared to UFH
Dec 8, 2006

Rimonabant update in the United States
Dec 5, 2006

New data shows Rimonabant benefited patients with type 2 diabetes by improving blood sugar control, reducing weight and acting on other cardiometabolic risk factors

First Rimonabant Trial with HbA1c as a Primary Endpoint
Nov 27, 2006

Sanofi Pasteur Completes Shipment of 50 Million Doses of Influenza Vaccine

Sanofi pasteur able to produce additional vaccine to meet customer demand
Nov 20, 2006

Sanofi Pasteur Signs Contract with U.S. Government for Stockpile of New Type of H5N1 Pre-Pandemic Vaccine

New pre-pandemic vaccine will provide additional level of preparedness

Show per page

Print
Email page
RSS

You are about to leave www.sanofi.us

If you wish to continue to this external website, click Proceed. It is provided for information only. Sanofi assumes no responsibility for the information presented on this website.